Comparison of treatment modalities for squamous cell carcinoma
Related Experiment Video
Updated: Nov 4, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
1Department of Dermatology, University of California, San Francisco, USA.
Abstract:
Numerous treatment modalities exist for cutaneous SCC. Having a variety of modalities in our armamentarium is useful, but they should be selected carefully based on certain key clinical and histologic prognostic factors. The histologic parameters should be provided to you by your dermatopathologist and can direct the clinician to better tailor treatment to specific neoplasms and thus produce more predictable outcomes. By incorporating the available prognostic factors in the literature, we can develop a reproducible schema or algorithmic approach to the treatment of cutaneous SCC to provide the highest cure rates possible while minimizing the morbidity for our patients (see Table 1).
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
